Download the appMore options
PisaczekSearch
文AEN-US
VaccinesStudies updated this month

COVID vaccines for children — what have we learned over the years?

Sources: 8 · Article: 12 173 characters ↓

What do Natural Therapy Specialists write?

Prof. Sucharit Bhakdi

By February 2021, VAERS reports indicated a link between myocarditis in young men and COVID vaccines.

„By the week of February 19th 2021, VAERS had received sufficient serious adverse event reports to implicate myocarditis in young males as causally connected to the COVID-19 vaccines with greater than 95% confidence [285]. Despite this available evidence of harm, on May 10, the FDA expanded the EUA for the Pfizer-BioNTech vaccine to include the 14 million Americans ages 12 through 15 years [286].”By the week of February 19th 2021, VAERS had received sufficient serious adverse event reports to implicate myocarditis in young males as causally connected to the COVID-19 vaccines with greater than 95% confidence [285]. Despite this available evidence of harm, on May 10, the FDA expanded the EUA for the Pfizer-BioNTech vaccine to include the 14 million Americans ages 12 through 15 years [286].
Prof. Sucharit Bhakdi

From December 2020 to December 2022, more than 4,000 reports concerning COVID vaccines in VAERS involved myocarditis.

„On May 27th, the CDC acknowledged adverse cardiac responses to vaccination, creating the webpage “Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination” on its website and stating [288]: Since April 2021, there have been increased reports to the Vaccine Adverse Event Reporting System (VAERS) of cases of inflammation of the heart. Between December 2020 and December 2022, over 4,000 (~ 0.16%) of the VAERS reports filed for COVID-19 vaccines were reports of myocarditis, 100 times as many events per vaccine dose as for influenza [280, 281].”On May 27th , the CDC acknowledged adverse cardiac responses to vaccination, creating the webpage “Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination” on its website and stating [288]: Since April 2021, there have been increased reports to the Vaccine Adverse Event Reporting System (VAERS) of cases of inflammation of the heart. Between December 2020 and December 2022, over 4,000 (~ 0.16%) of the VAERS reports filed for COVID-19 vaccines were reports of myocarditis, 100 times as many events per vaccine dose as for influenza [280, 281].
Prof. Sucharit Bhakdi

Prof. Sucharit Bhakdi describes studies that compared vaccinated and unvaccinated people and indicated that serious health problems occurred more often after vaccination.

„Despite repeated government health agency claims that these vaccines are safe for virtually all children and adults, numerous epidemiological studies reveal significantly increased incidences of serious health problems following these injections in the U.S. and around the world.”Despite repeated government health agency claims that these vaccines are safe for virtually all children and adults, numerous epidemiological studies reveal significantly increased incidences of serious health problems following these injections in the U.S. and around the world.
Prof. Sucharit Bhakdi

Prof. Sucharit Bhakdi says that more than 650 million doses of mRNA COVID vaccines had been given in the U.S. by December 2022.

„Between then and December 2022, over 650 million doses of mRNA COVID-19 vaccines were administered in the U.S. and nearly 13 billion worldwide [274]. Since the rollout of this vaccination program, individuals and health care practitioners have reported millions of adverse events following vaccination with the novel Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines.”Between then and December 2022, over 650 million doses of mRNA COVID-19 vaccines were administered in the U.S. and nearly 13 billion worldwide [274]. Since the rollout of this vaccination program, individuals and health care practitioners have reported millions of adverse events following vaccination with the novel Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines.
Jerzy Zięba

Jerzy Zięba cites a warning that people with allergies should not receive the Pfizer-BioNTech vaccine.

„United Kingdom suspends vaccinations for people prone to severe allergic reactions, https://www.medonet.pl/koronawirus-pytania-i-odpowiedzi/leczenie-koronawirusa,wielka-brytania-wstrzymuje-szczepienia-przeciwko-koronawirusowi-osob-ze-sklonnoscia-do-silnych-reakcji-alergicznych,artykul,19327261.html United Kingdom: no vaccinations for allergy sufferers, https://wydarzenia.interia.pl/news-wielka-brytania-szczepionka-nie-dla-alergikow,nId,4905192 People with allergies should not receive the vaccine made by Pfizer and BioNTech, https://www.rmf24.pl/raporty/raport-koronawirus-z-chin/najnowsze-fakty/news-osoby-z-alergiami-nie-powinny-przyjmowac-szczepionki-firmy-p,nId,4906551 British agency for”Wielka Brytania wstrzymuje sczepienia osób ze skłonnością do silnych reakcji alergicznych, https://www.medonet.pl/koronawirus-pytania-i-odpowiedzi/leczenie-koronawirusa,wielka-brytania-wstrzymuje-szczepienia-przeciwko-koronawirusowi-osob-ze-sklonnoscia-do-silnych-reakcji-alergicznych,artykul,19327261.html Wielka Brytania: szczepienia nie dla alergików, https://wydarzenia.interia.pl/news-wielka-brytania-szczepionka-nie-dla-alergikow,nId,4905192 Osoby z alergiami nie powinny przyjmować szczepionki firmy Pfizer i BioNTech, https://www.rmf24.pl/raporty/raport-koronawirus-z-chin/najnowsze-fakty/news-osoby-z-alergiami-nie-powinny-przyjmowac-szczepionki-firmy-p,nId,4906551 Brytyjska agencja ds.
Dr Norman Pieniążek

Dr. Norman Pieniążek claims that lipid nanoparticles containing mRNA can reach various cells and cause them to start producing the encoded substance.

„“This is a genetic preparation; I am a geneticist, so I can say honestly that it transforms cells. In other words, it enters any cells in the body—different cells in different people—from the brain, ovaries, heart, and liver; you can choose any organ. These lipid nanoparticles enter and transform the cell, so the cell suddenly starts producing what was encoded in the mRNA inside the lipid nanoparticle,” the professor reveals.”To jest preparat genetyczny, tzn. ja jestem genetykiem, więc mogę tak o tym szczerze powiedzieć, czyli transformują komórki. Czyli wchodzą do dowolnych komórek w organizmie, u jednego do tych, u jednego do innych, od mózgu, jajników, serca, wątroby, może pan wybrać jakikolwiek organ, wchodzą tam te nanocząsteczki lipidowe i transformują komórkę, czyli komórka nagle zaczyna produkować to, co było w tej nanocząsteczce lipidowej zakodowane w tym mRNA – ujawnia prof.
Dr Norman Pieniążek

Dr. Norman Pieniążek claims that problems with adverse reactions after COVID vaccination were known.

„“And all these problems with so-called adverse reactions following vaccination, with this so-called pseudo-vaccine (many people still do not understand what these vaccines—or rather, pseudo-vaccines—really are, as the professor notes—author’s note) were known!””– I te wszystkie problemy z tak zwanymi niepożądanymi odczynami poszczepiennymi, z tą tak zwaną pseudoszczepionką (do wielu nadal nie docierają informacje, czym tak naprawdę są te szczepionki – a właściwie pseudoszczepionki – jak zauważa profesor – uwaga autora) były znane!

What does scientific research from PubMed · Europe PMC say?

We selected 5 studies with the best, positive results. This is a selection, not a full review of all research.

Total number of studies on this topic in PubMed: 124.

Aim of the study: As the epidemic progresses, universal vaccination against COVID-19 has been the trend, but there are still some doubts about the efficacy and safety of COVID-19 vaccines in adolescents, children, and even infants. To evaluate the safety, immunogenicity, and efficacy of COVID-19 vaccines in the population aged 0-17 years.

Results: There was a total of six randomized controlled trials included in this systematic review and meta-analysis, enrolling participants in the age range of 3-17 years, and containing three types of COVID-19 vaccines. Compared with mRNA vaccines and adenovirus vector vaccines, inactivated vaccines have a more satisfactory safety profile, both after initial (RR 1.40, 95% CI 1.04-1.90, P = 0.03) and booster (RR 1.84, 95% CI 1.20-2.81, P = 0.005) vaccination. The risk of adverse reactions was significantly increased after the first and second doses, but there was no significant difference between the first two doses (RR 1.00, 95%CI 0.99-1.02, P = 0.60). Nevertheless, the two-dose regimen is obviously superior to the single-dose schedule for immunogenicity and efficacy.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studycombined analysis of many studies (meta-analysis)

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: The mass vaccination of children against coronavirus 2019 disease (COVID-19) has been frequently debated. The risk-benefit assessment of COVID-19 vaccination versus infection in children has also been debated. This systematic review looked for answers to the question "was the vaccination of our children valuable and successful?"

Results: The search results revealed that the majority of the reported adverse events after COVID-19 vaccination in pediatrics were mild to moderate, with few being severe. Injection site discomfort, fever, headache, cough, lethargy, and muscular aches and pains were the most prevalent side effects. Few clinical studies recorded significant side effects, although the majority of these adverse events had nothing to do with vaccination. In terms of efficacy, COVID-19 disease protection was achieved in 90-95% of cases for mRNA vaccines, in 50-80% of cases for inactivated vaccines, and in 58-92% of cases for adenoviral-based vaccines in children and adolescents. Based on available data, COVID-19 immunizations appear to be safe for children and adolescents. Furthermore, multiple studies have proven that different types of vaccines can provide excellent protection against COVID-19 in pediatric populations.

Money for the studynot stated
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studyreview of many studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Over 16 million children have been detected positive for the coronavirus disease 2019 (COVID-19) in the United States since the outbreak of the pandemic. In general, children infected with severe acute respiratory syndrome coronavirus type 2 tend to have lighter symptoms than adults.

Results: Although two doses of vaccine in children seem insufficient to prevent Omicron infection, the booster dose provides enhanced protection against infection and severe illness. Most importantly, the bivalent vaccine has been approved for use in the pediatric population to extend the immune response to currently circulating Omicron variant. And the immune protection afforded to newborns after maternal vaccination appears to last only 6 months. Therefore, in the current situation where the rate of virus mutation is accelerating and the COVID-19 pandemic is still severe, it is crucial to extend vaccine protection to children over 6 months of age to weave a tighter safety net.

Money for the studynot stated
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studydiscussion of other studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: A large-scale vaccination of coronavirus disease-19 (COVID-19) in adults has been conducted for nearly a year, and there is a growing recognition that immunization for children is also essential. It has been months since emergency use of pediatric COVID-19 vaccine was approved, we reviewed the prevalence and transmission of COVID-19 in children.

Results: The prevalence of COVID-19 in children is reduced due to vaccination even in a Delta prevalent period, so an increase in the vaccination rate is needed in children. Although the precise role of children in the transmission requires more research to uncover, they likely played a significant role, according to the available literature. We also described four candidate COVID-19 vaccines for children on their safety and immunogenicity and the impact of severe acute respiratory syndrome coronavirus 2 variants on childhood vaccination. Safety issues on pediatric vaccines post-approval, like adverse events following immunization and adverse events of special interest require studies on long-term and effective regulatory mechanisms.

Money for the studynot stated
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studydiscussion of other studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: The COVID-19 vaccine saved millions of lives during the pandemic. Clinical trials at the time of authorization and approval showed remarkable effectiveness.

Results: Coverage restrictions may further reduce population vaccinations rates, resulting in higher virus community load and prolonged circulation. Although the US regulatory framework requires insurers to cover vaccines included on the Centers for Disease Control and Prevention (CDC) Immunization Schedules without cost sharing, the future placement of COVID-19 vaccines on these schedules is uncertain. Given the evidence and population benefits, we support ICER's recommendation for private payers to cover COVID-19 vaccines with no patient cost sharing. We further recommend no restrictions on coverage based on risk factors, regardless of CDC Immunization Schedules, which have recently been subject to considerable uncertainty.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyother

“Not stated” does not mean nobody paid — the database does not always record it.

Sources (8)

Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.